Table 1 Correlation between IQGAP1 expression and clinicopathological variables in patients with PDAC.

From: IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling

Variables

Number

IQGAP1L (%)

IQGAP1H (%)

P*

Sex

Male

54

20 (37.0)

34 (63.0)

0.521

Female

33

10 (30.3)

23 (69.7)

 

Age a

≤61

44

16 (36.4)

28 (63.6)

0.709

>61

43

14 (32.6)

29 (67.4)

 

Tumor location

Pancreatic head

56

16 (28.6)

40 (71.4)

0.119

Non-head

31

14 (45.2)

17 (54.8)

 

Tumor size (cm)

<4

26

5 (19.2)

21 (80.8)

0.051

≥4

61

25 (41.0)

36 (59.0)

 

Histological differentiation

Well-moderate

66

27 (40.9)

39 (59.1)

0.034b

Poor

21

3 (14.3)

18 (85.7)

 

TNM stage

I + II

86

30 (34.9)

56 (65.1)

1b

III + IV

1

0 (0)

1 (100)

 

T classification

   

0.397

T1/T2

68

25 (36.8)

43 (63.2)

 

T3

19

5 (26.3)

14 (73.7)

 

N classification

N0

47

21 (44.7)

26 (55.3)

0.030

N1

40

9 (22.5)

31 (77.5)

 

M classification

M0

86

30 (34.9)

56 (65.1)

1b

M1

1

0 (0)

1 (100)

 

Perineural invasion

Present

35

10 (28.6)

25 (71.4)

0.341

Absent

52

20 (38.5)

32 (61.5)

 
  1. aMedian age; bFisher’s exact test.
  2. *P < 0.05 indicates a significant association among the variables.